- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02216812
Does Vitamin C Reduce Finger Stiffness After Distal Radius Fractures?
Does Vitamin C Reduce Finger Stiffness After Distal Radius Fractures? A Placebo Randomized Controlled Trial
The reported prevalence of disproportionate pain and disability among patients recovering from a fracture of the distal radius varies widely. Literature reports numbers between 1% and 37%, perhaps in part because it is poorly defined, known by so many different names, subjective, and unverifiable.
The investigators are interested in the effect of vitamin C after distal radius fractures on objective measurement of finger motion, patient reported outcome measures, and pain intensity, instead of the previously used, subjective and imprecise criteria for complex regional pain syndrome.
Patients presenting to the Hand and Orthopaedic Trauma Services of MGH with a distal radius fracture will be asked to participate in this clinical trial. Patient will be randomly assigned to take either placebo or vitamin C 500 mg until full finger motion is attained as regarded by the treating physician at follow-up or for 6 weeks.
The investigators hypothesize no difference in finger stiffness at 6 weeks measured by distance to palmar crease of the index through little finger between patients taking vitamin C or placebo after a distal radius fracture. Additionally, the investigators assess finger stiffness by range of motion and stiffness of the thumb, and difference in PROMIS upper extremity function and pain score both measured at six months.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02114
- Massachusetts General Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- All adult (age 18 or greater) patients presenting to the Hand and Orthopaedic Trauma Services of the Massachusetts General Hospital (MGH) within two weeks of a fracture of the distal radius, either operatively or nonoperatively treated
Exclusion Criteria:
- Patients with severe kidney failure, known allergy for vitamin C or pregnancy
- Multiple fractures, except for ulna fractures
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 500 mg vitamin C
Arm will take 1 pill of 500 mg vitamin C per day for 6 weeks
|
|
|
Placebo Comparator: Placebo
Arm will take 1 placebo pill per day for 6 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Distance to Palmar Crease Index Through Small Finger
Time Frame: Day 1 (baseline), 6 weeks
|
To establish the distance to palmar crease, we asked patients to make a fist and determine the distance from nail tip to palmar crease for each individual digit using a ruler.
We defined total distance to palmar crease as the sum of the values for the index, long, ring, and small fingers.
|
Day 1 (baseline), 6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Active Flexion Index Through Small Finger
Time Frame: Day 1 (baseline), 6 weeks
|
Active flexion will be measured using a handheld goniometer.
We calculate total active flexion of the index through small finger by summing flexion at the metacarpo-phalangeal, proximal interphalangeal and distal interphalangeal joints
|
Day 1 (baseline), 6 weeks
|
|
Thumb Motion
Time Frame: Day 1 (baseline), 6 weeks
|
Total active range of motion at the thumb combines active flexion at the metacarpo-phalangeal and interphalangeal joint, as well as palmar andabduction
|
Day 1 (baseline), 6 weeks
|
|
PROMIS Upper Extremity - CAT
Time Frame: Day 1 (baseline), 6 weeks, 6 months
|
The Patient Reported Outcome Information System (PROMIS) Upper Extremity Computer Adaptive Test (CAT) is a computerized assessment measuring the physical function of the upper extremity.
It is scored using a T-score, and the average is 50 for the U.S. population.
In a given PROMIS, a T-score above 50 represents more of the measured variable than the average.
For this variable, a T-score above 50 indicates greater physical function than the average population.
|
Day 1 (baseline), 6 weeks, 6 months
|
|
0-10 Ordinal Pain Score
Time Frame: Day 1 (baseline), 6 weeks, 6 months
|
Measure Description: The Ordinal Pain Scale measures the amount of pain on a scale from 0, no pain, to 10, worst possible pain.
The investigators will compare the change in pain between the two cohorts after 6 weeks of treatment and 6 months after treatment.
|
Day 1 (baseline), 6 weeks, 6 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2014P000561
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.